Impact of modification of the standard intraperitoneal paclitaxel/cisplatin chemotherapy regimen on progression-free survival

被引：0
|
作者：
Lesnock, J. [1 ]
Chu, T. [1 ]
Richard, S. [2 ]
Kubenik, M. [1 ]
Krivak, T. [1 ]
Zorn, K. [1 ]
Sukumvanich, P. [1 ]
Kelley, J. [1 ]
Edwards, R. [1 ]
机构：
[1] Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Magee Womens Hosp, Wexford, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [21] Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study
    Chang, Yen-Hou
    Lu, Chien-Hsing
    Yen, Ming-Shyen
    Lee, Wai-Hou
    Chang, Yi
    Chang, Wei-Pin
    Chuang, Chi-Mu
    CHINESE JOURNAL OF CANCER, 2016, 35
  • [22] Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study
    YenHou Chang
    ChienHsing Lu
    MingShyen Yen
    WaiHou Lee
    Yi Chang
    WeiPin Chang
    ChiMu Chuang
    ChineseJournalofCancer, 2016, 35 (05) : 264 - 267
  • [23] Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis
    Takano, Masashi
    Sugiyama, Toru
    Yaegashi, Nobuo
    Suzuki, Mitsuaki
    Tsuda, Hiroshi
    Sagae, Satoru
    Udagawa, Yasuhiro
    Kazuo, Kuzuya
    Kigawa, Junzo
    Takeuchi, Satoshi
    Tsuda, Hitoshi
    Moriya, Takuya
    Kikuchi, Yoshihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (04) : 256 - 260
  • [24] Impact of Race on Progression-Free Survival and Overall Survival in Patients with Multiple Myeloma
    Wani, Kashmira
    Gutta, Radhika
    Mittal, Aayush
    Jamil, Maria
    Springer, Kylie
    Kuriakose, Philip
    BLOOD, 2023, 142
  • [25] Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis
    Masashi Takano
    Toru Sugiyama
    Nobuo Yaegashi
    Mitsuaki Suzuki
    Hiroshi Tsuda
    Satoru Sagae
    Yasuhiro Udagawa
    Kazuo Kuzuya
    Junzo Kigawa
    Satoshi Takeuchi
    Hitoshi Tsuda
    Takuya Moriya
    Yoshihiro Kikuchi
    International Journal of Clinical Oncology, 2007, 12 : 256 - 260
  • [26] An Audit Strategy for Progression-Free Survival
    Dodd, Lori E.
    Korn, Edward L.
    Freidlin, Boris
    Gray, Robert
    Bhattacharya, Suman
    BIOMETRICS, 2011, 67 (03) : 1092 - 1099
  • [27] Long Progression-free Survival by Pemetrexed Continuation Maintenance Therapy Following Cisplatin-based Chemotherapy in Malignant Pleural Mesothelioma
    Takeda, Takayuki
    Itano, Hideki
    Fukita, Shinichi
    Saitoh, Masahiko
    Takeda, Sorou
    INTERNAL MEDICINE, 2014, 53 (20) : 2347 - 2351
  • [28] Bevacizumab 'prolongs progression-free survival'
    Saul, Helen
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (12) : 2136 - 2136
  • [29] Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study
    Tiersten, Amy D.
    Moon, James
    Smith, Harriet O.
    Wilczynski, Sharon P.
    Robinson, William R., III
    Markman, Maurie
    Alberts, David S.
    ONCOLOGY, 2009, 77 (06) : 395 - 399
  • [30] Effects of combined sintilimab and chemotherapy on progression-free survival and overall survival in osteosarcoma patients with metastasis
    Li, Fan
    Zhang, De-bao
    Ma, Yue
    Song, Yang
    Duan, Xian-liang
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (04) : 648 - 651
12345